250+ investors that invest in your industry and stage
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Art
Web3
Organic Food
Wellness
Big Data
Video Games
Publishing
B2B
Android
Food and Beverage
Payments
Real Estate
Finance
Education
Digital Media
Financial Services
Retail
Manufacturing
Infrastructure
Beauty
Photography
Biotechnology
Construction
Travel
Fitness
Recruiting
Hospitality
Mobile Advertising
Sports
Platforms
Cannabis
Franchise
Automotive
Social
Wine And Spirits
eSports
Medical Device
Crowdfunding
Mobile
CleanTech
Enterprise Software
Mobile Apps
Transportation
Music
InsurTech
Email
Enterprise
Social Media
Social Network
Medical
LGBT
Legal
Local
Internet
SaaS
Oil and Gas
Fashion
Film
Life Science
Theatre
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Machine Learning
Cryptocurrency
Facebook
Agriculture (agtech)
Media (entertainment)
Blockchain
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Ghana
Armenia
Egypt
Belarus
Hungary
Saudi Arabia
Finland
France
Croatia
Oceania
Gibraltar
Barbados
Georgia
Greece
Africa
Czech Republic
Faroe Islands
Costa Rica
LATAM
Hong Kong
Bahrain
Belgium
Asia
Denmark
Brazil
Bermuda
Estonia
Algeria
Liechtenstein
Ecuador
Bulgaria
Panama
Belize
Chile
Ethiopia
Togo
Rwanda
Slovenia
Poland
Uganda
San Marino
Myanmar
Sweden
Lithuania
Serbia
Sierra Leone
Thailand
Tanzania
Uzbekistan
Zambia
Malaysia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
Peru
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Liberia
Ukraine
Jersey
Lebanon
Taiwan
Dominican Republic
Norway
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
Mexico
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Italy
Luxembourg
Pakistan
Albania
Mali
Philippines
Romania
Israel
Jordan
Grenada
Argentina
Bangladesh
Kuwait
Mauritius
Malta
Morocco
Nicaragua
Kazakhstan
Kenya
Cambodia
Cayman Islands
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Guatemala
Colombia
Seychelles
Marshall Islands
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Medical Device VC (Venture Capital) Funds in Oceania in January 2026

A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in Oceania. We rank investors based on the number of investments they made in Medical device companies from Oceania. We update this investor list every month.

Top 50 Medical Device VC (Venture Capital) Funds in Oceania in January 2026

Investor Medical Device Oceania investments
Brandon Capital 8
Artesian VC 6
Medical Research Commercialisation Fund (MRCF) 6
Sydney Angels 4
Melbourne Angels 4
Pacific Channel 4
Icehouse Ventures 4
IP Group 3
Global from Day One 3
Significant Ventures 3
Cure Kids Ventures 3
Uniseed 3
Uniservices 3
New Zealand Growth Capital Partners 3
Breakthrough Victoria 3
Flying Kiwis 2
K1W1 2
GD1 2
Punakaiki Fund 2
Uniseed Ventures 2
Brisbane Angels 2
Global Health Investment Fund (GHIF) 2
Matū Group 2
Flying Kiwi Angels 2
Regal Funds Management 2
IP Group Australia 1
Playford Capital 1
Upswell Ventures 1
Venture-Store Pty Ltd 1
Sante Ventures 1
Skip Capital 1
Bridgewest Group 1
SFC Capital 1
LCO Capital 1
South Australian Venture Capital Fund 1
Terra Rossa Capital 1
Hostplus 1
Right Click Capital 1
Booster 1
Dexcom Ventures 1
Khosla Ventures 1
Archangel Ventures 1
National Vision 1
Grand Challenges Canada 1
UniSA Ventures 1
OneVentures 1
Powerhouse Ventures 1
Sirius Capital 1
BridgeLane Capital 1
Movac 1

Reach every investor

Get a list of investors who already back your industry, stage, and country. Emails & phones included.

Find investors — It's Free!
Investor list
Brandon Capital
VC Fund · Melbourne, Victoria, Australia · 1 investment in the past 12 months

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Software, Artificial Intelligence, Health Care
  • Seed, Pre-Seed, Series A
  • Australia, United States, Hong Kong

Portfolio highlights

  • Voltavate — Voltavate is dedicated to driving innovation in battery technology to support the global transition towards sustainable energy solutions.
  • SAMA Fertility — SAMA Fertility is a virtual fertility clinic that offers fertility care and treatments, including preservation and evaluation services.
  • Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Show all investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show all investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Software, Health Care, SaaS
  • Seed, Angel, Series A
  • Australia, United States

Portfolio highlights

  • Okkular — Okkular is an AI based fashion tech startup.
  • iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
  • Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Show all investments...

Melbourne Angels
VC Fund · Melbourne, Victoria, Australia · 1 investment in the past 12 months

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

Show more...

Investment focus

  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand

Portfolio highlights

  • Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
  • Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
  • Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
Show all investments...

Pacific Channel
VC Fund · Auckland, Auckland, New Zealand · 1 investment in the past 12 months

Investing in great people solving hard problems to create a better future.

Show more...

Investment focus

  • Medical Device, Medical, Information Technology
  • Seed, Series A
  • New Zealand, Australia

Portfolio highlights

  • PHNXX — PHNXX provides containerised clean and reliable energy solutions for business operations.
  • Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
  • Green Gravity — Green Gravity is an electric power generation company that enables renewable energy transition using energy storage technology.
Show all investments...

Icehouse Ventures
VC Fund · Auckland, Auckland, New Zealand

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States, United Kingdom

Portfolio highlights

  • Foxglove — Foxglove is visualization and management for temporal and multimodal data. It's used by robotics companies to scale and accelerate development.
  • Antioch — Antioch is the development and simulation platform for autonomy teams to accelerate timelines, rigorously evaluate autonomous systems, and deploy with confidence.
  • HealthNow — HealthNow provides accessible healthcare services that give you control of your health. Manage how you access care, when you need it.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 2 investments in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Australia

Portfolio highlights

  • Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Show all investments...

Global from Day One
VC Fund · Auckland, Auckland, New Zealand

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Show more...

Investment focus

  • Software, SaaS, Medical Device
  • Seed, Series A, Funding Round
  • New Zealand, United States, China

Portfolio highlights

  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

Significant Ventures
VC Fund · Canberra, Australian Capital Territory, Australia · 1 investment in the past 12 months

Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy

Show more...

Investment focus

  • Manufacturing, Information Technology, Software
  • Seed, Series A, Funding Round
  • Australia

Portfolio highlights

  • Wavewise Analytics — Cyban is a medical equipment manufacturing company that manufactures brain oxygen monitors.
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • Visionary Machines — Superior perception for next-generation autonomy
Show all investments...

Cure Kids Ventures
VC Fund · Auckland, Auckland, New Zealand

Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to

Show more...

Investment focus

  • Medical Device, SaaS, Medical
  • Seed, Pre-Seed, Series A
  • New Zealand

Portfolio highlights

  • chnnl — Optimise your employee wellbeing strategy with chnnl. Centralised resource management, track psychosocial risks and team psychological wellbeing measurement.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

Uniseed
VC Fund · Brisbane, Queensland, Australia

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • VeriQuantix — VeriQuantix was spun out of the University of Queensland. VeriQuantix is an Australian startup specializing in cybersecurity, focusing on quantum technology to enhance the security of optical fiber communication networks. Their core innovation, Quantum Link Verification (QLV), is designed to detect and alert network operators to physical tappingattempts and intercept cyber attacks on fiber optic networks. This technology leverages quantum principles, specifically entangled photons, to verify the trustworthiness of network links by ensuring that any unauthorized access disrupts photon entanglement and triggers immediate alerts.
  • Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Show all investments...

Uniservices
VC Fund

Auckland University's commercialisation arm

Show more...

Investment focus

  • Medical Device, SaaS, Audio
  • Seed, Pre-Seed
  • New Zealand

Portfolio highlights

  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

New Zealand Growth Capital Partners
VC Fund

The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States

Portfolio highlights

  • Scannable — Scannable helps Arborists, Rope Access Technicians, Riggers, and Rescuers easily manage PPE and safety equipment.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Show all investments...

Breakthrough Victoria
VC Fund · Melbourne, Victoria, Australia

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

Show more...

Investment focus

  • Manufacturing, Health Care, Software
  • Funding Round, Series A, Seed
  • Australia, United States, Philippines

Portfolio highlights

  • DeepDerm — DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies.
  • InnovaIVF — InnovaIVF transforms the reproductive technology landscape with innovative solutions.
  • Mental Jam — We are a games studio dedicated to ​creating impactful experiences that ​explore mental health.
Show all investments...

Flying Kiwis
VC Fund

Super-seeded by new entry: Flying Kiwi Angels

Show more...

Investment focus

  • SaaS, 3D Technology, Medical Device
  • Seed
  • New Zealand

Portfolio highlights

  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Show all investments...

K1W1
VC Fund · Auckland, Auckland, New Zealand · 1 investment in the past 12 months

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

Show more...

Investment focus

  • Software, Artificial Intelligence, Biotechnology
  • Seed, Series A, Funding Round
  • New Zealand, United States

Portfolio highlights

  • Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
  • Factor — Plug and play forecasting and pricing tools for modern energy utilities.
  • Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Show all investments...

GD1
VC Fund · Auckland, Auckland, New Zealand · 2 investments in the past 12 months

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Series A, Pre-Seed
  • New Zealand, United States, China

Portfolio highlights

  • EarnOS — EarnOS is the fully remote company that provides Global Ad & Payments Platform powered by Web3.
  • Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
  • Ivo — Ivo reduces the time, effort, and cost of negotiating agreements.
Show all investments...

Punakaiki Fund
VC Fund · Auckland, Auckland, New Zealand · 1 investment in the past 12 months

Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.

Show more...

Investment focus

  • Software, SaaS, Information Technology
  • Funding Round, Seed, Series B
  • New Zealand, United States

Portfolio highlights

  • Astute Access — Astute is using smart locks and cloud software, our enterprise solutions deliver a robust, scalable access control solution.
  • Projectworks — Project Works is a cloud based workforce management platform designed to help professional & creative services businesses better manage their organisations in the areas of project management, project financials, and people management. Our mission is to provide a platform that enables world class services businesses to get the most out of theirexisting workforce, and enable them to grow.
  • Quantifi Photonics — The world evolves, and so do we. As optical communication technologies find new applications, our...
Show all investments...

Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom

Portfolio highlights

  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Show all investments...

Brisbane Angels
VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

Show more...

Investment focus

  • Information Technology, Software, Artificial Intelligence
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand

Portfolio highlights

  • Tendl — Write tenders faster with Tendl's AI tool. Keep your data private and secure. Easy installation, no sharing. Boost productivity and streamline your contract opportunities.
  • Shopfront — Automate multi-channel selling across eBay, Depop, Grailed & Shopify. AI-powered listings, bulk uploads, inventory sync.
  • Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
Show all investments...

Global Health Investment Fund (GHIF)
VC Fund · New York, New York, United States

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria

Portfolio highlights

  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

Matū Group
VC Fund · Auckland, Auckland, New Zealand

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

Show more...

Investment focus

  • Biotechnology, Robotics, Nanotechnology
  • Seed
  • New Zealand, United States

Portfolio highlights

  • Ligar — Revolutionising molecular extraction through nanotechnology (molecularly imprinted polymers)
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
Show all investments...

Flying Kiwi Angels
VC Fund · Auckland, Auckland, New Zealand

Flying Kiwi Angels ? Helping Kiwi Startups

Show more...

Investment focus

  • Software, Information Technology, Apps
  • Seed, Angel, Pre-Seed
  • New Zealand

Portfolio highlights

  • FileInvite — The simplest, most secure, document collection platform for professionals. Request files, forms, data and e-signatures all through a secure client portal.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Kara Technologies — Content accessibility using a signing avatar. Accessible solutions are at the core of all that we do here at Kara. One of our main goals is finding smarter ways of using technology that will help build a better future for everyone, in all areas of life.
Show all investments...

Regal Funds Management
VC Fund · Sydney, New South Wales, Australia

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Show more...

Investment focus

  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom

Portfolio highlights

  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
  • Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
Show all investments...

IP Group Australia
VC Fund · Surry Hills, New South Wales, Australia · 1 investment in the past 12 months

Ip Group Australia build and support outstanding intellectual property-based companies.

Show more...

Investment focus

  • Biotechnology, Manufacturing, Health Care
  • Seed, Pre-Seed, Series A
  • Australia, New Zealand

Portfolio highlights

  • Azaneo — Azaneo develops lightning-fast electric weeding technology. Using only electrons - herbicide free.
  • Hysata — Hysata is a developer of hydrogen electrolyzer designed to accelerate the world's shift away from fossil fuels to green hydrogen
  • ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
Show all investments...

Playford Capital
VC Fund · Adelaide, South Australia, Australia

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia

Portfolio highlights

  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Show all investments...

Upswell Ventures
VC Fund · Perth, Western Australia, Australia

We're an early-stage venture capital firm investing in technology companies at the Seed and Series A stage.

Show more...

Investment focus

  • Software, Developer Tools, Apps
  • Seed, Series A, Funding Round
  • Australia, Canada, United Kingdom

Portfolio highlights

  • Amaka — Accounting integrations and automation solutions for SMBs. Sync data from POS and e-commerce business apps to Xero, QuickBooks, MYOB and more.
  • Riparide — Riparide helps you plan and book your next escape through our Storyteller travel guides. These guides, called Riparide Stories, come packed with unique stays, local adventures and social vibes....
  • Lasertrade — Lasertrade is an online marketplace that offers a wide range of medical devices and equipment for the healthcare sector.
Show all investments...

Venture-Store Pty Ltd
VC Fund · Melbourne, Victoria, Australia

Only a few year ago, it took $ millions to get a tech venture to market; $1m before cutting a line of code, another $1m or so to get v1.0 into customers hands, millions more refining it.​That was for a start up. Multiply it times over for a large corporate.Then, assuming it was a product people used/wanted, millions to scale it. If theproduct/market fit wasn't there, millions more to pivot, chase a business model.​Today ideas can be conceived, tested, architected, teams added, capabilities assembled, services built, deployed, at scale, globally for a fraction of the cost and time.Venture-Store is founded upon this profound shift: ideas with unicorn scale, potential, shipped to market rapidly, inexpensively, by anyone from anywhere in the world.The scale, sophistication and configurability of tech is fuelling unprecedented innovation throughout business and society. Markets are up for grabs, open to new, better ways of solving problems and creating value for consumers. For entrepreneurs, start ups, corporations and investors the game is changing. Earlier access to new ventures is more important than ever to investment returns.

Show more...

Investment focus

  • Wellness, Blockchain, Health Care
  • Seed
  • Australia

Portfolio highlights

  • Helfie.ai — Helfie AI is a groundbreaking mobile platform that enables easy, instant and affordable health checks for a wide range of conditions. Helfie-Backed by science.
Show all investments...

Sante Ventures
VC Fund · Austin, Texas, United States

Privately Held Companies

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Series B, Series C
  • United States, Canada, Australia

Portfolio highlights

  • OutcomesAI — OutcomesAI operates as a healthcare company, that combines AI Voice Agents with licensed nurses to deliver safe, scalable care across health systems.
  • Apreo Health — Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
  • ABK Biomedical — At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors
Show all investments...

Skip Capital
VC Fund · Sydney, New South Wales, Australia · 9 investments in the past 12 months

Skip Capital is a private investment fund investing in technology and infrastructure

Show more...

Investment focus

  • Software, Artificial Intelligence, SaaS
  • Series A, Seed, Series B
  • Australia, United States, Canada

Portfolio highlights

  • Askable — Askable offers a comprehensive research platform that facilitates access to certified researchers and verified participants globally. The platform streamlines the research process from recruitment to analysis, enabling teams to gather insights efficiently.
  • Visibuild — Visibuild is a construction software web & mobile platform providing real-time insights, workflows, defect tracking, ITPs inspections.
  • GROWL — Discover GROWL: the smart boxing bag blending cardio, strength, and gaming. Experience an immersive home boxing coach and step up your performance.
Show all investments...

Bridgewest Group
VC Fund · San Diego, California, United States

Bridgewest Group, private investment firm with global investments in innovative software, semiconductor, life sciences and biotech, and AI is empowering people for a better tomorrow.

Show more...

Investment focus

  • Mobile, Hardware, Internet
  • Seed, Funding Round
  • New Zealand, United States

Portfolio highlights

  • Gimbal — The world's best brands and agencies rely on Infillion for advertising and software solutions that connect people, places, and digital experiences.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Show all investments...

SFC Capital
VC Fund · London, England, United Kingdom

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Pre-Seed, Seed, Funding Round
  • United Kingdom, United States, Canada

Portfolio highlights

  • TILKI — TILKI is an AI-powered game creation platform that democratizes video game development by enabling all creators to build immersive games without coding.
  • ZERØTEC — ZERØTEC is an pattern design and nesting software platform for fashion designers and manufacturers
  • Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
Show all investments...

LCO Capital
VC Fund · Raleigh, North Carolina, United States

LCO Capital offer value-add financial and intellectual capital to underperforming business lines, using an LCO℠ business model.

Show more...

Investment focus

  • Health Care, Manufacturing, Medical Device
  • Funding Round
  • New Zealand

Portfolio highlights

  • Chitogel — Chitogel is a medical device company that offers edge wound healing gel for use in endoscopic sinus surgery.
Show all investments...

South Australian Venture Capital Fund
VC Fund · Adelaide, South Australia, Australia

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

Show more...

Investment focus

  • Health Care, Biotechnology, SaaS
  • Funding Round, Series A, Series B
  • Australia

Portfolio highlights

  • Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Show all investments...

Terra Rossa Capital
VC Fund · Adelaide, South Australia, Australia

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia

Portfolio highlights

  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Show all investments...

Hostplus
VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months

Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!

Show more...

Investment focus

  • Software, Biotechnology, Renewable Energy
  • Series A, Series B, Series C
  • Australia, United Kingdom, United States

Portfolio highlights

  • Airwallex — Grow your business faster with Airwallex - global business accounts, high speed transfers, multi-currency cards, online payments, embedded finance, and more.
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
  • Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Show all investments...

Right Click Capital
VC Fund · Sydney, New South Wales, Australia

Right Click Capital - Australian Venture Capital Firm

Show more...

Investment focus

  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Australia, Singapore, United States

Portfolio highlights

  • black.ai — Build smarter spaces with Black.ai
  • Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
  • Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Show all investments...

Booster
VC Fund · Wellington, Wellington, New Zealand · 1 investment in the past 12 months

Booster is an investment manager, superannuation and default KiwiSaver scheme provider. We offer ethical, New Zealand and specialist investment options.

Show more...

Investment focus

  • Medical Device
  • Seed
  • New Zealand

Portfolio highlights

  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Bontia Bio — Bontia Bio is dedicated to creating natural parasiticides for crop protection and animal health.
  • PowerON — Dielectric Elastomers for Soft Robotics
Show all investments...

Dexcom Ventures
VC Fund · San Diego, California, United States

The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

Show more...

Investment focus

  • Sensor, Medical, Wearables
  • Funding Round
  • Australia

Portfolio highlights

  • Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
Show all investments...

Khosla Ventures
VC Fund · Menlo Park, California, United States

Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.

Show more...

Investment focus

  • Software, Artificial Intelligence, Health Care
  • Series A, Series B, Seed
  • United States, India, United Kingdom

Portfolio highlights

  • Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
  • Vectra AI — Vectra is the world leader in AI threat detection and response. The Cognito platform uses AI to detect attackers in real time and perform conclusive investigations.
  • Point One Navigation — Precise Positioning for the next generation of transportation. 10cm accuracy everywhere.
Show all investments...

Archangel Ventures
VC Fund · Melbourne, Victoria, Australia

Archangel is an early stage venture capital fund based in Australia. We work with great founders and investors to build game changing companies together.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Seed, Pre-Seed, Series A
  • Australia, United States, Philippines

Portfolio highlights

  • GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
  • OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
  • Termina — Termina operates as an energy tech startup.
Show all investments...

National Vision
VC Fund · Duluth, Georgia, United States

National Vision is the second largest and one of the fastest growing optical retail companies in the U.S., helping people to see their best to live their best. Learn more about National Vision Inc. and how to join our team.

Show more...

Investment focus

  • Health Care, Social Media, Digital Media
  • Seed, Series A
  • New Zealand, United States

Portfolio highlights

  • Toku Eyes — Instant Healthcare Diagnostics. Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics...
  • Digital Vision Systems — DigitalVision develops, manufactures, and distributes a technology platform for analyzing and correcting vision disorders. It offers vision simulators and prescribers, and spectacles and contact lenses. The company was founded in 2004 and is based in Atlanta, Georgia.
Show all investments...

Grand Challenges Canada
VC Fund · Toronto, Ontario, Canada

Learn how we find, fund and support high-impact innovations

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Grant, Seed, Debt Financing
  • Canada, United States, Australia

Portfolio highlights

  • OmniVis — OmniVis is a technology company creating handheld devices to rapidly detect dangerous pathogens - saving food and saving lives.
  • Hewatele — Hewatele is a social enterprise that provides affordable quality medical oxygen to all needy patients together with its affiliates CPHD and Mediquip Global.
  • Nivi — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
Show all investments...

UniSA Ventures
VC Fund

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Seed
  • Australia

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Show all investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel

Portfolio highlights

  • Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
  • StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
  • Employment Hero — Employment Hero is Australia's top cloud-based HR, payroll and benefits platform for employers & employees. FREE trial for...
Show all investments...

Powerhouse Ventures
VC Fund · Christchurch, Canterbury, New Zealand · 1 investment in the past 12 months

powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures

Show more...

Investment focus

  • Solar, FinTech, Big Data
  • Seed, Series A, Funding Round
  • United States, France, New Zealand

Portfolio highlights

  • Granular — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
  • Granular Energy — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
  • Liquid Instruments — Redefining the way scientists, engineers, students, and professionals experience test and measurement with Moku software-reconfigurable hardware platforms
Show all investments...

Sirius Capital
VC Fund · Beijing, Beijing, China

Sirius Capital is a venture capital firm in China that invests in technology companies.

Show more...

Investment focus

  • Artificial Intelligence, Video, Retail
  • Series A, Seed, Series C
  • China, Australia

Portfolio highlights

  • Vantari VR — Virtual Reality for Healthcare
  • Vastai Technologies — Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.
  • Kuanfen Technology Realcome — Kuanfen Technology Realcome is a brand of AI virtual bloggers that focuses on the use of various AI technologies.
Show all investments...

BridgeLane Capital
VC Fund · Sydney, New South Wales, Australia

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Show more...

Investment focus

  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany

Portfolio highlights

  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Show all investments...

Movac
VC Fund · Wellington, Wellington, New Zealand · 2 investments in the past 12 months

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

Show more...

Investment focus

  • Software, E-Commerce, SaaS
  • Seed, Series A, Funding Round
  • New Zealand, United States, Australia

Portfolio highlights

  • Atomic — Atomic embeds native, actionable customer interaction inside your iOS, Android or web app. Turn your customer data and insights into loyalty, retention and conversion.
  • ZeroJet — ZeroJet is the first jet propulsion system to be designed specifically for an electric motor, delivering the perfect balance of performance and runtime.
  • Mint Innovation — Founded in 2016, members of the Mint Innovation team have a strong background in chemistry, biotechnology, and leveraging IP in the industrial sector. They are scaling their technology in their Auckland plant and labs to demonstrate the commercial application of their biometallurgy processes for metal recovery.
Show all investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in Oceania by industry

Contact investors today

Find who invests in your industry, stage, and country in 5 minutes.

Find investors — It's Free!